Farnesylacetate, Geranyl,
Gefarnate,
Gefarnil,
Gepharnate,
Geranyl Farnesylacetate,
Ulco,
gefarnate,
51-77-4,
Gefarnyl,
Geranyl farnesylacetate,
Gefarnil,
Gefarnatum [INN-Latin],
UNII-1ISE2Y6ULA,
3,7-dimethylocta-2,6-dien-1-yl 5,9,13-trimethyltetradeca-4,8,12-trienoate,
Gefarnato [INN-Spanish],
DA-688,
Gefarnate [INN:BAN:JAN],
EINECS 200-121-0,
1ISE2Y6ULA,
[(2E)-3,7-dimethylocta-2,6-dienyl] (4E,8E)-5,9,13-trimethyltetradeca-4,8,12-trienoate,
NCGC00182546-01,
(E,E,E)-5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester,
DSSTox_CID_28562,
DSSTox_RID_82834,
DSSTox_GSID_48636,
4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, (2E)-3,7-dimethyl-2,6-octadienyl ester, (4E,8E)-,
Gefarnatum,
Gefarnato,
5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid 3,7-dimethyl-2,6-octadienyl ester,
CAS-51-77-4,
trans-3,7-Dimethyl-2,6-octadienyl 5,9,13-trimethyl-4,8,12-tetradecatrienoate,
4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester, (E,E,E)-,
Gepharnate,
Gefanil,
Osteol,
Ulco,
16898-88-7,
AC1NQZMH,
AC1Q65TM,
SCHEMBL148495,
3,7-dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-trienoate,
CHEMBL2105085,
DTXSID0048636,
CHEBI:31646,
4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, (2E)-3,7-dimethyl-2,6-octadien-1-yl ester, (4E,8E)-,
HY-B2206,
ZINC3872668,
Tox21_112983,
DA 688,
MFCD00129086,
NSC138947,
AKOS015966756,
Tox21_112983_1,
AC-2134,
CS-7652,
DB12079,
NSC-138947,
NCGC00182546-02,
111GE003,
AJ-46365,
AN-14257,
AS-15887,
BC680174,
SC-26456,
LS-148920,
051G774,
I14-106586,
4,8,12-Tetradecatrienoic acid, 5,9,13-trimethyl-, 3,7-dimethyl-2,6-octadienyl ester,(E,E,E)-,
dixnalate,
Gefarnate [BAN:INN:JAN],
C27H44O2,
EINECS 240-942-1,
C27-H44-O2,
CID5282182,
R260,
A13666,
geranyl5,9,13-trimethyltetradeca-4,8,12-trienoate,
3,7-Dimethylocta-2,6-dienyl 5,9,13-trimethyltetradeca-4,8,12-enoate,
(4E,8E)-5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid (2E)-3,7-dimethyl-2,6-octadienyl ester,